Banacos Cica-Aid Centella Peptide Toner

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for application by sprinkling evenly on the face.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

After cleansing the skin in the morning and evening, an appropriate amount of the product should be applied. The user is advised to take the desired quantity from the foundation makeup stage and spread it evenly over the face, neck, and any other areas as preferred. It is important to ensure uniform coverage for optimal results.

Contraindications

Use is contraindicated in areas with wounds due to the potential for irritation or adverse effects. Additionally, contact with the eyes should be avoided to prevent possible ocular complications.

Warnings and Precautions

For external use only, this product must be handled with care to ensure safety. It is imperative to keep the product away from fire or flame to prevent any hazardous incidents. Users should avoid spraying the product on clothing, as it may cause staining. Additionally, caution should be exercised to prevent contact with the eyes; in the event of contact, the eyes should be rinsed thoroughly with water.

General precautions include refraining from using the product on areas with wounds, as this may exacerbate irritation or lead to complications. Eye contact should be strictly avoided to prevent potential damage or discomfort.

In the event of side effects such as red spots, swelling, or itching, particularly those arising from cosmetic use or exposure to direct sunlight, it is crucial to discontinue use and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. The product is intended for external use only, and it is crucial to keep it away from fire or flame to prevent any hazardous situations. Additionally, users should avoid spraying the product on clothing, as it may cause staining.

Care should be taken to prevent contact with the eyes. In the event of accidental exposure, it is recommended to wash the eyes thoroughly with water. If patients experience any side effects, such as red spots, swelling, or itching, particularly in response to cosmetic use or direct sunlight, they should stop using the product and consult a healthcare professional for further guidance.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Banacos Cica-Aid Centella Peptide Toner (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Safety and efficacy in pediatric populations have not been established, and caution is advised when considering its use in this demographic.

Geriatric Use

There is no specific information regarding the use of BANACOS CICA-AID CENTELLA PEPTIDE TONER in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this product to elderly patients, as the absence of data necessitates careful monitoring and consideration of individual patient factors.

Pregnancy

There is no specific information regarding the use of BANACOS CICA-AID CENTELLA PEPTIDE TONER in pregnant patients. The drug insert does not provide safety concerns, dosage modifications, or special precautions related to its use during pregnancy. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits before recommending this product to pregnant patients.

Lactation

There are no specific statements or considerations regarding lactation or nursing mothers in the provided text. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk remain unspecified. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients, although specific parameters are not defined in the prescribing information.

Overdosage

There is currently no information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any adverse effects and to follow standard protocols for managing potential overdose situations. In the absence of specific overdosage data, it is recommended that clinicians exercise caution and consider supportive care as necessary.

Nonclinical Toxicology

No relevant information was found regarding teratogenic effects, non-teratogenic effects, or any nonclinical toxicology data. Additionally, there is no available information pertaining to animal pharmacology and toxicology.

Postmarketing Experience

Reports received through voluntary submissions and surveillance programs have indicated that some patients may experience side effects such as red spots, swelling, or itching, particularly in relation to cosmetic use or exposure to direct sunlight. It is advised that individuals experiencing these symptoms consult their healthcare provider for further evaluation and management.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. It is important to inform patients that the product should not be applied to areas with wounds, as this may lead to irritation or complications.

Patients should be cautioned to avoid contact with the eyes. Providers should emphasize the importance of taking care not to get the product into the eyes, as this could result in discomfort or adverse effects.

Additionally, healthcare providers should instruct patients to monitor for any side effects, such as red spots, swelling, or itching, which may occur due to cosmetic use or exposure to direct sunlight. If any of these symptoms arise, patients should be encouraged to consult their doctor for further evaluation and guidance.

Storage and Handling

The product is supplied in a manner that ensures safety and efficacy. It is essential to keep the product away from fire or flame to prevent any hazardous situations. Additionally, care should be taken to avoid spraying the product on clothing, as it may cause staining.

To ensure safety, the product must be kept out of reach of children. Proper handling and storage are crucial to maintain the integrity of the product and to safeguard against accidental exposure.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to discontinue use and consult a doctor if they experience side effects such as red spots, swelling, or itching, particularly in response to cosmetic products or direct sunlight. Patients should also be advised to avoid contact with the eyes; in the event of contact, they should rinse thoroughly with water. Additionally, the product should be kept out of reach of children.

Drug Information (PDF)

This file contains official product information for Banacos Cica-Aid Centella Peptide Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)